Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>The English winemaker reports results for the FY period to 31 December 2025. There is a 19% increase in revenue to £19.4m, with a small decline in gross margin to 47.1% from 48.4%.</li>
<li>The EBITDA is £3.75m against £2.98m, and PBT is £0.469k compared to a £1,400k loss in the prior period. Stocks increased 15% to £30.6m and net debt increased to £12.4m from £9.4m.</li>
<li>The headroom on the £20m revolving credit facility remains in place, with an accordion option to extend the facility to £30m. </li>
</ul>


The English winemaker reports results for the FY period to 31 December 2025. There is a 19% increase in revenue to £19.4m, with a small decline in gross margin to 47.1% from 48.4%.
The EBITDA is £3.75m against £2.98m, and PBT is £0.469k compared to a £1,400k loss in the prior period. Stocks increased 15% to £30.6m and net debt increased to £12.4m from £9.4m.
The headroom on the £20m revolving credit facility remains in place, with an accordion option to extend the facility to £30m. 


ハイブリダン小型株の祭典：2026年4月29日

Futura Medical

ハイブリダン小型株の祭典：2026年4月29日